Tonix Pharmaceuticals
TNXP
TNXP
19 hedge funds and large institutions have $2.99M invested in Tonix Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
73% less capital invested
Capital invested by funds: $11.1M → $2.99M (-$8.14M)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$662K | |
| 2 | +$141K | |
| 3 | +$123K | |
| 4 |
Two Sigma Investments
New York
|
+$108K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$108K |
Top Sellers
| 1 | -$5.05M | |
| 2 | -$712K | |
| 3 | -$123K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$80K |
| 5 |
Squarepoint
New York
|
-$75K |